Pharmacist-Bilal Asghar

Pharmacist-Bilal Asghar Protect your health, thus protecting your lif

🔍 Spot the Error...🧾 MOCK PRESCRIPTION CHALLENGE:A 30-year-old Female is diagnosed with Malaria and is prescribed this m...
01/09/2025

🔍 Spot the Error...
🧾 MOCK PRESCRIPTION CHALLENGE:
A 30-year-old Female is diagnosed with Malaria and is prescribed this medication. But wait — there’s a clear pharmacological mistake here! 🧐

Can you figure out what doesn’t belong in this treatment plan?

💡 HINT: Wrong Medication Included ❌

 ’s Role in Preventing Harm – Beyond Dispensing:A patient presents a prescription for Ciprofloxacin, a commonly prescrib...
27/08/2025

’s Role in Preventing Harm – Beyond Dispensing:
A patient presents a prescription for Ciprofloxacin, a commonly prescribed fluoroquinolone antibiotic. Upon observation, the pharmacist notes that the individual appears to be heavily involved in weightlifting or resistance training. Recognizing this as a potential risk factor, the pharmacist considers the broader implications before dispensing the medication.

Clinical Insight:
Fluoroquinolones, particularly Ciprofloxacin, are associated with serious musculoskeletal side effects, including:

Tendonitis

Tendon rupture

These risks are significantly increased in individuals who engage in intense physical activity, such as heavy weightlifting, due to the stress placed on tendons during training. The Achilles tendon is especially vulnerable.

Pharmacist Action:
Rather than dispensing the medication immediately, the pharmacist chooses to:

Review the patient profile and risk factors

Contact the prescribing physician:

Suggest a safer alternative antibiotic, if clinically appropriate, considering the patient's infection type, severity, and possible drug interactions

This proactive approach not only avoids a potentially severe adverse drug reaction but also reinforces the pharmacist’s role as a critical safety checkpoint in the healthcare system.

🩸🌍 World’s Rarest Blood Type Discovered: Gwada NegativeIn a groundbreaking discovery, scientists in France have identifi...
16/08/2025

🩸🌍 World’s Rarest Blood Type Discovered: Gwada Negative

In a groundbreaking discovery, scientists in France have identified a brand-new blood group—Gwada Negative—making it the 48th officially recognized blood group system worldwide.

🧬 First found in a woman from Guadeloupe during routine surgery prep, her blood carried a mysterious antibody. After years of research and DNA analysis, scientists confirmed a unique genetic mutation passed down from both parents.

📌 She remains the only known person in the world with this blood type—meaning she’s only compatible with herself.

🌐 Named "Gwada" after her Caribbean roots, this discovery could help improve care for rare blood type patients globally.

🩸 One in the world. One in a lifetime. Meet: Gwada Negative.

Reference https://www.sciencealert.com/scientists-identifynew-blood-group-and-its-the-worlds-rarest

*Use of metformin in adults with diabetes linked to lower risk of long COVID* A recent NIH-funded study shows that adult...
17/05/2025

*Use of metformin in adults with diabetes linked to lower risk of long COVID*

A recent NIH-funded study shows that adults with type 2 diabetes who take metformin have a lower risk of developing long COVID or dying from a COVID-19 infection compared to those taking other anti-diabetes medications. The study, which analyzed health data from nearly 38 million Americans, found a 13-21% reduction in long COVID or death in metformin users. This builds on earlier research showing metformin reduced long COVID risk by 40% in non-diabetic adults. The exact mechanism remains unclear but may involve reduced inflammation and viral levels. Metformin should only be used under medical supervision!

02/03/2025
05/02/2025

🚨 ANTIBIOTIC RESISTANCE CRISIS IN PAKISTAN: WE CAN’T STAY SILENT! 🚨

📊 SHOCKING STATS:

88% of pharmacies give antibiotics WITHOUT prescriptions (vs.

Why???
22/12/2024

Why???

The FDA approved Wegovy (semaglutide) injection for reducing the risk of cardiovascular death, heart attack, and stroke ...
15/12/2024

The FDA approved Wegovy (semaglutide) injection for reducing the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight, along with a calorie-restricted diet and increased physical activity. It's the first weight loss medication with this indication. Wegovy contains semaglutide, a GLP-1 receptor agonist, and shouldn't be used with other semaglutide products or GLP-1 agonists. It significantly reduces major adverse cardiovascular events. However, it carries a boxed warning for thyroid C-cell tumors and should be avoided in patients with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Common side effects include nausea, diarrhea, and abdominal pain. It's also approved for long-term weight reduction in certain adults and children with obesity.

The use of intravenous nitroglycerin is contraindicated in patients with constrictive pericarditis, pericardial tamponad...
09/12/2024

The use of intravenous nitroglycerin is contraindicated in patients with constrictive pericarditis, pericardial tamponade, or restrictive cardiomyopathy. In these patients, cardiac output is dependent upon venous return, which can be reduced by nitroglycerin due to venous pooling. Also, nitroglycerin-induced hypotension may lead to paradoxical bradycardia and increased angina pectoris.

Concurrent use of Warfarin and Foods Rich in Vitamin K may reduce Warfarin’s effectivenessTalk to your doctor before con...
17/11/2024

Concurrent use of Warfarin and Foods Rich in Vitamin K may reduce Warfarin’s effectiveness
Talk to your doctor before consuming foods high in vitamin K (such as kale, spinach, or broccoli) while on Warfarin. These foods can reduce Warfarin's effectiveness, increasing the risk of blood clots and stroke. Maintaining a consistent intake of vitamin K is important for stable blood thinning effects. Be sure to inform your doctor about any dietary changes.

Address

Islamabad
Islamabad
44000

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+923185320115

Website

Alerts

Be the first to know and let us send you an email when Pharmacist-Bilal Asghar posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pharmacist-Bilal Asghar:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram